| Product Code: ETC12463386 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Morocco Imatinib Drug Market Overview |
3.1 Morocco Country Macro Economic Indicators |
3.2 Morocco Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Morocco Imatinib Drug Market - Industry Life Cycle |
3.4 Morocco Imatinib Drug Market - Porter's Five Forces |
3.5 Morocco Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Morocco Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Morocco Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Morocco Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Morocco Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Morocco Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in Morocco |
4.2.2 Growing awareness and diagnosis of CML patients leading to higher demand for imatinib drug |
4.2.3 Favorable government initiatives and policies supporting access to essential medicines |
4.3 Market Restraints |
4.3.1 High cost associated with imatinib drug leading to affordability issues for patients |
4.3.2 Limited healthcare infrastructure and access to specialized treatment centers |
4.3.3 Stringent regulatory requirements and approval processes for new drugs |
5 Morocco Imatinib Drug Market Trends |
6 Morocco Imatinib Drug Market, By Types |
6.1 Morocco Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Morocco Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Morocco Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Morocco Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Morocco Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Morocco Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Morocco Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Morocco Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Morocco Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Morocco Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Morocco Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Morocco Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Morocco Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Morocco Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Morocco Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Morocco Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Morocco Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Morocco Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Morocco Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Morocco Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Morocco Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Morocco Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Morocco Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Morocco Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Morocco Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Morocco Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Morocco Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Morocco Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Morocco Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Morocco Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Morocco Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Morocco Imatinib Drug Market Import-Export Trade Statistics |
7.1 Morocco Imatinib Drug Market Export to Major Countries |
7.2 Morocco Imatinib Drug Market Imports from Major Countries |
8 Morocco Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib treatment |
8.2 Number of healthcare professionals trained in managing CML and prescribing imatinib |
8.3 Average time taken for regulatory approval of new imatinib drug formulations |
8.4 Rate of successful treatment outcomes among CML patients using imatinib |
8.5 Percentage of CML patients in Morocco receiving imatinib as the first-line treatment option |
9 Morocco Imatinib Drug Market - Opportunity Assessment |
9.1 Morocco Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Morocco Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Morocco Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Morocco Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Morocco Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Morocco Imatinib Drug Market - Competitive Landscape |
10.1 Morocco Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Morocco Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here